Nuvalent Inc vs New York Times Co — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while New York Times Co trades at $75.56 (market cap $12.29B). The key difference: New York Times Co is the larger of the two by market cap, and New York Times Co pays a 1.21% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | NYT | |
|---|---|---|
Market Cap | $9.81B | $12.29B |
Sector | Technology | Media |
52-Week High | $123.96 | $85.86 |
52-Week Low | $72.16 | $51.43 |
Enterprise Value | $8.52B | $11.68B |
Dividend Yield | — | 1.21% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Read more on NYT →